Ambrx Biopharma Inc ADR (AMAM)
28.00 +0.02 (+0.07%) 03/07/24 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -77,996 | -68,288 | -17,839 | -22,313 | N/A |
| Depreciation Amortization | 1,293 | 2,154 | 1,943 | 2,053 | N/A |
| Accounts receivable | 863 | -811 | 415 | -762 | N/A |
| Accounts payable and accrued liabilities | -1,829 | 2,403 | -3,247 | 3,776 | N/A |
| Other Working Capital | -10,621 | 3,640 | -7,375 | 14,176 | N/A |
| Other Operating Activity | 19,615 | 16,262 | 5,527 | 305 | 0 |
| Operating Cash Flow | $-68,675 | $-44,640 | $-20,576 | $-2,765 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -45,664 | N/A | N/A | N/A | N/A |
| PPE Investments | -1,054 | -1,956 | -252 | -48 | N/A |
| Purchase Sale Intangibles | N/A | -1,250 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -1,250 | 0 | 0 | 0 |
| Investing Cash Flow | $-46,718 | $-3,206 | $-252 | $-48 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 166,000 | N/A | 1,339 | N/A | N/A |
| Common Stock Issued | 138 | 148,732 | N/A | N/A | N/A |
| Other Financing Activity | -165,210 | -21,305 | 94,339 | 0 | 0 |
| Financing Cash Flow | $928 | $127,427 | $95,678 | $N/A | $N/A |
| Exchange Rate Effect | N/A | 47 | 165 | -38 | N/A |
| Beginning Cash Position | 170,906 | 91,278 | 16,263 | 19,114 | N/A |
| End Cash Position | 56,441 | 170,906 | 91,278 | 16,263 | N/A |
| Net Cash Flow | $-114,465 | $79,628 | $75,015 | $-2,851 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -68,675 | -44,640 | -20,576 | -2,765 | N/A |
| Capital Expenditure | -1,054 | -1,956 | -252 | -48 | N/A |
| Free Cash Flow | -69,729 | -46,596 | -20,828 | -2,813 | 0 |